会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明授权
    • Long chain carboxylic acid maleimides
    • 长链羧酸马来酰亚胺
    • US5360914A
    • 1994-11-01
    • US59759
    • 1993-05-11
    • Masayasu InoueIwao EbashiTetsuo Takigawa
    • Masayasu InoueIwao EbashiTetsuo Takigawa
    • A61K38/44C12N9/02A61K37/50C07D207/452C07K15/12
    • C12N9/0089
    • Provided are novel superoxide dismutase derivatives represented by the following general formula (I) ##STR1## wherein [SOD] is a superoxide dismutase residue derived by removal of two mercapto groups, and W is a divalent long chain hydrocarbon residue which may optionally be interrupted by one or more groups each independently selected from the group consisting of an oxygen atom, a sulfur atom and a group of -N(R)- (R being a lower alkyl group). The SOD derivatives retain most of the enzymatic activities of unmodified SOD and have much longer plasma half-life than unmodified SOD. They are effective for treating various diseases caused by active oxygen species.Also provided are chemical modifiers to prepare the above SOD derivatives.
    • 提供了由以下通式(I)表示的新型超氧化物歧化酶衍生物,其通过除去两个巯基衍生得到的酪蛋白酶残基,W是二价长链烃残基,其可以任选地被一个或多个各自独立地选自 由氧原子,硫原子和-N(R) - (R为低级烷基)的基团组成。 SOD衍生物保留大部分未修饰的SOD的酶活性,并且具有比未修饰的SOD更长的血浆半衰期。 它们对于治疗由活性氧引起的各种疾病是有效的。 还提供了制备上述SOD衍生物的化学改性剂。
    • 5. 发明授权
    • Superoxide dismutase derivatives
    • 超氧化物歧化酶衍生物
    • US5238837A
    • 1993-08-24
    • US803414
    • 1991-12-06
    • Masayasu InoueIwao EbashiTetsuo Takigawa
    • Masayasu InoueIwao EbashiTetsuo Takigawa
    • A61K38/44C12N9/02
    • C12N9/0089
    • Provided are novel superoxide dismutase derivatives represented by the following general formula (I) ##STR1## wherein [SOD] is a superoxide dismutase residue derived by removal of two mercapto groups, and W is a divalent long chain hydrocarbon residue which may optionally be interrupted by one or more groups each independently selected from the group consisting of an oxygen atom, a sulfur atom and a group of --N(R)-- (R being a lower alkyl group). The SOD derivatives retain most of the enzymatic activities of unmodified SOD and have much longer plasma half-life than unmodified SOD. They are effective for treating various diseases caused by active oxygen species.Also provided are chemical modifiers to prepare the above SOD derivatives.
    • 提供了由以下通式(I)表示的新型超氧化物歧化酶衍生物:其中[SOD]是通过除去两个巯基衍生的超氧化物歧化酶残基,W是可任意选择的二价长链烃残基 被一个或多个各自独立地选自氧原子,硫原子和-N(R) - (R是低级烷基)的基团的基团中断)。 SOD衍生物保留大部分未修饰的SOD的酶活性,并且具有比未修饰的SOD更长的血浆半衰期。 它们对于治疗由活性氧引起的各种疾病是有效的。 还提供了制备上述SOD衍生物的化学改性剂。